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The origins of our current understanding of control of transcription elongation lie in pioneering experiments that mapped RNA
polymerase II on viral and cellular genes. These studies ﬁrst uncovered the surprising excess of polymerase molecules that we now
know to be situated at the at the 5 ends of most genes in multicellular organisms. The pileup of pol II near transcription start
sites reﬂects a ubiquitous bottle-neck that limits elongation right at the start of the transcription elongation. Subsequent seminal
work identiﬁed conserved protein factors that positively and negatively control the ﬂux of polymerase through this bottle-neck,
and make a major contribution to control of gene expression.
1.Introduction
The initiation phase of the RNA polymerase II (pol II) tran-
scription cycle involves multiple events, including recruit-
ment of general transcription factors and pol II to the pro-
moter, melting of the DNA template, initiation of RNA
synthesis, and pol II promoter clearance, which marks entry
intotheelongationphase.Thestochasticnatureofallofthese
steps poses a potential problem if it becomes necessary to
mount a rapid activation of transcription. Following initia-
tion pol II often encounters a rate-limiting barrier that
appears to lie between early elongation and productive elon-
gation. The transition between these two phases of the tran-
scription cycle has now been characterized as a powerful reg-
ulatoryswitchusedtoincreaseordecreasegeneexpressionin
a signal-responsive fashion. Here we review the early discov-
eries that laid the foundation for a detailed understanding of
transcriptional regulation at this transition.
2. EarlyEvidence of Polymerase Pausingand
PrematureTermination in DNA Viruses
Nearly 30 years ago it was reported by the late Yosef Aloni
and colleagues that run-on transcripts made in nuclei from
SV40 infected cells were strongly biased toward the 5 end of
the late transcription unit suggesting that pol II accumulated
in the promoter-proximal region [1]. Analysis of labeled
RNA extended on viral transcription complexes (VTCs)
assembled in vivo and puriﬁed from infected cells revealed
two additional unusual features of transcription from the
late promoter. First, two pause sites were mapped around
positions +15 and +40 relative to the start site by identifying
the junctions between unlabelled RNA made in vivo and
labeled RNA extended in vitro [2]. Second, a major product
of transcription on VTCs is a discrete 93–95 base RNA,
that is, prematurely terminated near a potential hairpin loop
structure. Similar evidence for promoter-proximal stalling
and/or premature termination were subsequently reported
for the early and late promoters of polyoma virus [3]. These
results prompted speculation that SV40 late transcription
might be regulated by a mechanism [1] that regulates a deci-
sion between premature termination and productive elon-
gation, analogous to attenuation on bacterial operons [4].
About the same time Luse and colleagues showed that tran-
scription complexes assembled in HeLa nuclear extract on
the adenovirus 2 major late promoters under NTP limiting
conditions gave rise to uncapped transcripts about 20 nu-
cleotideslongthatcouldbeelongatedintocappedtranscripts2 Genetics Research International
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Figure 1: RNA pol II density proﬁle across a typical metazoan pro-
tein-coding gene. Elevated density around the transcription start
site (TSS) results from promoter-proximal pausing and possibly
premature termination of transcription. Blue and green arrows
denote divergent transcription from the TSS. A second peak of
pol II accumulation downstream of the poly (A) site precedes
termination coupled to cleavage/polyadenylation. Black arrows
denote termination of transcription with eviction of pol II (yellow
circles) from the DNA template downstream of the poly (A) site
(red arrow) and possibly also in the promoter-proximal region. The
mRNA cap structure is denoted by a white circle.
upon NTP addition [5]. The implication of this result is that
pol II can pause at relatively discrete positions near the tran-
scription start site and remain competent to resume elon-
gation. They called this phenomenon “promoter-proximal
pausing.” Together these seminal early studies revealed quite
unexpected patterns of stalling, pausing, and premature ter-
mination by host cell’s pol II when it transcribes certain viral
genes. The question posed by these studies was whether this
unusual behavior by pol II was peculiar to viral genes or
shared in common with cellular genes.
3.Pol IIPile-Ups on CellularGenes
It was not long before the ﬁrst evidence emerged that pol
II also piles up near the transcription start sites of cellular
genes. High levels of pol II were found to accumulate at the
5 ends of the Drosophila heat shock gene hsp70 [6, 7], and
human c-myc genes even though the genes were not actively
expressed [8, 9]. These 5 polymerases were not only able
to incorporate labeled NTPs in the nuclear run-on reaction
but were also resistant to sarkosyl. Moreover, in some cases
they were demonstrated to be associated with a single-
stranded transcription bubble showing deﬁnitively that they
were actively engaged on the template [10]. Subsequent run-
on studies revealed that pol II was distributed with a sim-
ilar strong bias in favor of the promoter-proximal region
on Hsp26 and GAPDH in Drosophila [11] and adenosine
deaminase, c-fos, DHFR and transthyretin genes in mam-
mals [12–15]. As a footnote several of these early nuclear
runon studies detected transcription proceeding in both
directions from the start site, but the signiﬁcance of this
divergent transcription remained obscure [8, 16]. These
results therefore showed that the pattern of pol II ac-
cumulation near start sites, ﬁrst observed in DNA viruses,
was common to a number of cellular genes. In fact it
emerged from these early studies that pol II accumulated
near the TSS of most or all cellular genes where it was local-
ized in suﬃcient detail. Based on this evidence Krumm
and colleagues suggested in 1995 that promoter-proximal
pausing was a “general rate-limiting step” in the pol II tran-
scription cycle[17]. Recently, this prediction has been largely
borne out by ChIP-seq and Gro-Seq studies that localiz-
ed pol II genome-wide and found high levels of pol II ac-
cumulation at the start sites of thousands of genes in Dro-
sophila and human cells [18–20]. Indeed in human cell lines
relatively few genes have a uniform distribution of pol II
throughout their length compared to those with a promoter-
proximal pol II pile-up (H. Kim, S. Kim, K. Brannan and D.
Bentley unpublished observations). Promoter-proximal pol
II accumulation likely involves sequence elements upstream
and downstream of the start site as well as chromatin
structure[21–23].WhilethedetailsofwhatmakespolIIpile-
up near start sites remain somewhat obscure, this is clearly a
characteristic shared by numerous promoters (Figure 1).
4. Promoter-ProximalPausingversus
Premature Termination
What is the root cause for why pol II is so unevenly
distributed across so many genes? The original in vitro pulse
chase experiments of Coppola and colleagues showed that
pol II can pause close to the start site and then resume elon-
gation [5]. Since then, the most popular interpretation of in
vivo polymerase mapping studies has been that they result
from a similar “promoter-proximal pausing” phenomenon.
That at least some promoter-proximal polymerase can re-
sume elongation is demonstrated by nuclear runon exper-
iments; indeed, these polymerases would not be detectable
by this method if they could not elongate and incorporate
labeled nucleotides. However, the possibility that some frac-
tion of the promoter-proximal polymerases terminate pre-
maturely and never enter the productive elongation phase
cannot be eliminated. The evidence for premature termi-
nation is quite clear for the SV40 late and HIV viral genes
[24, 25] ,b u ti ti sm u c hl e s sc o m p e l l i n gf o rc e l l u l a rg e n e s .
Prematurely terminated RNAs are a major product of c-
myc transcription in microinjected Xenopus oocytes, but
the physiological relevance of this phenomenon remains un-
proven [26]. Recently, short (20–90 bases) transcription
start site-associated (TSS-a) sense and antisense transcripts
present at very low levels in the nucleus were detected by
high-throughput RNA sequencing [27]. Whether these tran-
scripts are products of promoter-proximal premature termi-
nation or pol II pausing are interesting questions for future
investigation.
5. The Function of Polymerase Accumulation at
Start Sites
An important question to emerge from the early studies of
pol II localization on viral and cellular genes was: “What
is the purpose of pol II piling up at the start sites of genes
even before they are activated?” One answer to this question
quickly emerged from studies of three genes with regulated
transcriptionaloutput:thecellularHsp70andc-mycgenes[6,
8, 9] and a transfected reporter driven by the HIV1 LTR [24].
In each of these cases nuclear run-on transcription revealedGenetics Research International 3
ak e yd i ﬀerence between the activated and nonactivated
states: the ratio of polymerases within the gene body relative
tothe5 endincreasedwhentranscriptionwasactivated.The
signiﬁcance of these studies is that they showed regulation of
gene expression can be exerted at the level of transcriptional
elongationbycontrollingthefractionofpolymerasesthatare
permitted to travel beyond the promoter-proximal region.
Furthermore at Hsp70, the amount of paused pol II prior
to heat shock correlated with the amount of mRNA made
after heat shock [23]. Therefore, a satisfying answer to
the question of why pol II accumulates near start sites is
that it provides a pool of engaged polymerases ready for
rapid mobilization in response to a gene activation stimulus.
A second way that localized pol II accumulation at the
TSS may enhance rapid transcriptional responses is exclud-
ing nucleosomes, thereby providing a bookmark in the chro-
matin that can be easily accessed by the transcriptional
machinery [22]. A third suggestion is that an extended pol
II dwell time within the promoter proximal region allows for
cotranscriptionalcappingofthenascentmRNA[28,29],and
could help to “license” productive elongation complexes by
allowing time for recruitment of processing and elongation
factors. On the other hand, there is no direct evidence that a
pol II pile-up near the TSS is required for eﬃcient capping.
6. Control of Elongation by
TranscriptionalActivators
How is the ﬂux of pol II from the promoter-proximal region
into the body of a gene controlled? The ﬁrst important
clue was again provided by a virus; in this case HIV1.
GroundbreakingworkofKaoandcolleaguesshowedthatthe
viraltransactivatorproteinTathadthenovelabilitystimulate
elongationbypolII[24].WithoutTat,mostpolymerasesthat
initiate from the HIV1 LTR terminate prematurely shortly
downstream of the TAR hairpin loop sequence in a manner
resembling the SV40 late transcription unit, but in the pres-
ence of Tat, pol II acquires the ability to extend transcripts all
thewaytotheendoftheprovirus.Toexplainthesesurprising
results,Kaoetal.suggestedthatTatregulatestranscriptionby
an antitermination mechanism similar to that exerted by the
bacteriophage lambda N protein [30]. However, it remained
possible that Tat also controlled transcriptional pausing,
which is frequently a pre-requisite for termination.
HIV Tat is an unusual transactivator because it binds
to the nascent RNA transcript. Therefore, the question re-
mainedopenastowhetherconventionalDNA-boundactiva-
tors can inﬂuence transcriptional elongation. Part of the
answertothisquestioncamewiththedemonstrationthatTat
couldactivatetranscriptionwhentetheredtoaDNA-binding
siteinthepromoter[31].Subsequentstudiesshowedthaten-
hancers and promoter-bound chimeric transcription factors
comprising activation domains fused to a DNA-binding
domain can stimulate elongation [32]. Furthermore a num-
ber of natural cellular activators stimulate elongation includ-
ing heat-shock factor, NFkB, and c-myc [21, 33, 34]. Ac-
tivation domains that enhance elongation and initiation,
respectively, can synergize with one another and the most
potent activation domains such as Herpes virus VP16 can
stimulate both initiation and elongation [35, 36].
7. The Yinand Yangof ElongationalControl
How do activators like HIV Tat and cellular transcription
factors stimulate pol II transit away from the promoter-
proximal region and into the downstream region of the gene
for productive mRNA synthesis? The solution to this prob-
lem was provided by landmark studies that uncovered novel
inhibitorsofelongationandthefactorsthatantagonizethem.
This story started with an early insight into how the ATP
analogue 5, 6-dichloro-1-ß-D-ribofuranosylbenzimidazole
(DRB) inhibits pol II transcription. Pulse labeling of RNA in
adenovirus-infected cells revealed that DRB inhibited chain
elongation but not initiation [37]. In a tour de force of classi-
cal biochemistry, the Handa and Price labs took advantage of
thisinhibitortoidentifythecorenegativeandpositivefactors
thatcontrolthe“yinandyang”oftranscriptional elongation.
Handa’s lab identiﬁed the DRB-sensitivity-inducing factor
(DSIF) as Spt4/5 a conserved pol II binding complex that
is required for inhibition of elongation near 5 ends [38].
Soon afterwards, these workers identiﬁed a second negative-
elongation factor, NELF, that cooperates with DSIF [39]. The
counterpart to these negative factors is positive transcription
elongation factor b (PTEFb) discovered by Marshall and
Price [40]. PTEFb was identiﬁed as the cyclin-dependent
protein kinase complex Cdk9-CyclinT1 [41, 42] that is spec-
iﬁcally inhibited by DRB. In a remarkable convergence of
independent studies, it turned out that the negative-factors
DSIF and NELF and the positive-factor PTEFb are all com-
ponents of the same control system. Thus, a major function
of PTEFb is to “alleviate” the negative eﬀects of DSIF and
NELF [43] which it does by phosphorylating them both as
w e l la st h ep o lI IC - t e r m i n a ld o m a i n[ 44, 45].
Elucidation of the interplay between positive- and nega-
tive-elongation factors provided a basis for understanding
how transcription factors can regulate elongation. The vital
missing piece of the puzzle was ﬁlled in with the discovery
that Tat when bound to TAR in the nascent HIV1 transcript
contacts PTEFb through Cyclin T1 and this interaction is
required for stimulation of transcriptional elongation [41,
42, 46]. Tat-mediated recruitment of PTEFb permits mod-
iﬁcation of the paused pol II complex by phosphorylation
of the pol II CTD, Spt5, and NELF resulting in a transition
to productive elongation. A similar mechanism involving
PTEFb-mediated antagonism of the negative-elongation
factors DSIF and NELF is thought to regulate elongation at
many cellular genes including c-fos and NFkB targets [45,
47]. PTEFb (Cdk9/CyclinT1) is found embedded in multi-
ple complexes with diﬀerent protein and RNA subunits [48,
49] and there are likely to be multiple ways that it can be
recruited to genes. These include binding directly to tran-
scription factors [33] and chromatin components [50].
8. Concluding Remarks
Tremendous advances have been made in understanding
control of gene expression at the level of transcriptional4 Genetics Research International
elongation since the early days when it was identiﬁed on a
few viral and cellular genes. Now this mechanism is recog-
nized to be at least as important as control of the initiation
step in pol II transcription. Still, important questions
remain unresolved about the nature of promoter-proximally
accumulated pol II. It is still not clear how many of these
paused polymerases have backtracked and are destined ulti-
mately to resume elongation and how many are destined for
premature termination. These scenarios suggest the possi-
bility of distinct targets for regulation by controlled poly-
merase release into the body of the gene. It will be interes-
ting to see how these targets might be used in various de-
velopmental and signal-responsive contexts.
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